Stuttgart - Delayed Quote EUR

Onward Medical N.V. (63E.SG)

Compare
6.32
+0.92
+(17.04%)
At close: January 10 at 3:37:04 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cost of Revenue
--
--
14,687.00
11,980.00
2,309.00
Gross Profit
--
--
-14,687.00
-11,980.00
-2,309.00
Operating Expense
35,835.00
35,463.00
32,028.00
16,553.00
13,204.00
Operating Income
-35,432.00
-35,463.00
-32,028.00
-28,533.00
-15,513.00
Net Non Operating Interest Income Expense
215.00
-421.00
-1,486.00
-5,613.00
-4,441.00
Pretax Income
-35,407.00
-36,074.00
-33,538.00
-34,245.00
-19,994.00
Tax Provision
-256.00
107.00
-766.00
69.00
20.00
Net Income Common Stockholders
-35,151.00
-36,181.00
-32,772.00
-34,314.00
-20,014.00
Diluted NI Available to Com Stockholders
-35,151.00
-36,181.00
-32,772.00
-34,314.00
-20,014.00
Basic EPS
-1.09
--
-1.09
-3.62
-3.39
Diluted EPS
-1.09
--
-1.09
-3.62
-3.39
Basic Average Shares
32,405.50
--
30,184.00
9,485.00
5,900.00
Diluted Average Shares
32,405.50
--
30,184.00
9,485.00
5,900.00
Total Operating Income as Reported
-35,432.00
-35,463.00
-32,028.00
-28,532.00
-15,512.00
Total Expenses
35,432.00
35,463.00
32,028.00
28,533.00
15,513.00
Net Income from Continuing & Discontinued Operation
-35,151.00
-36,181.00
-32,772.00
-34,314.00
-20,014.00
Normalized Income
-35,151.00
-36,181.00
-32,772.00
-34,314.00
-20,014.00
Interest Income
--
972.00
62.00
1.00
--
Interest Expense
--
1,376.00
1,515.00
5,597.00
4,430.00
Net Interest Income
215.00
-421.00
-1,486.00
-5,613.00
-4,441.00
EBIT
-34,667.00
-34,698.00
-32,023.00
-28,648.00
-15,564.00
EBITDA
-33,836.00
-33,972.00
-31,288.00
-28,319.00
-15,293.00
Reconciled Cost of Revenue
--
--
14,687.00
11,980.00
2,309.00
Reconciled Depreciation
831.00
726.00
735.00
329.00
271.00
Net Income from Continuing Operation Net Minority Interest
-35,151.00
-36,181.00
-32,772.00
-34,314.00
-20,014.00
Normalized EBITDA
-33,836.00
-33,972.00
-31,288.00
-28,319.00
-15,293.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 10/25/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMVIF IMV INC
0.0001
0.00%
 
AYJ.HA Valneva SE
2.2060
+4.45%
 
AYJ.DE Valneva SE
2.2340
+5.48%
 
ALNFL.PA NFL Biosciences SA
1.8700
+1.63%
 
4RD.F MaaT Pharma SA
8.34
-4.79%
 
IVA Inventiva S.A.
2.1700
-2.25%
 
HYL.BR Hyloris Pharmaceuticals SA
6.08
0.00%
 
TUB.BR Financière de Tubize SA
151.40
-0.13%
 
UCB.BR UCB SA
195.10
-0.86%
 
GLPG.AS Galapagos NV
25.06
-6.00%